London, United Kingdom

Carlotta Petticone

This inventor holds 1 USPTO granted patent. Top assignee: Autolus Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlotta Petticone. Retrieved from https://idiyas.com/inventor/carlotta-petticone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlotta Petticone: Innovator in T Cell Preparation

Introduction

Carlotta Petticone is a distinguished inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the preparation of T cells for therapeutic applications. Her innovative work has the potential to advance treatments for various diseases.

Latest Patents

Carlotta holds a patent for a method of preparing T cells with increased activity. The patent describes a process that involves providing a starting population of cells, depleting those that express a target antigen, and introducing a nucleic acid sequence encoding a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR). This method aims to create genetically modified cells that can be used in pharmaceutical compositions for the treatment and prevention of diseases.

Career Highlights

Carlotta is currently associated with Autolus Limited, where she continues to develop her groundbreaking research. Her work is pivotal in the field of immunotherapy, focusing on enhancing the efficacy of T cells in combating diseases.

Collaborations

Some of her notable coworkers include Martin Pulé and James Faulkner, who contribute to the collaborative efforts at Autolus Limited.

Conclusion

Carlotta Petticone's innovative approach to T cell preparation exemplifies the advancements being made in biotechnology. Her contributions are paving the way for new therapeutic strategies in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…